Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020

Epidemiol Serv Saude. 2023;32(1):e2022563. doi: 10.1590/S2237-96222023000300004.
[Article in English, Portuguese]

Abstract

Objective: to analyze treatment delay and the flow of care for women with breast cancer in Brazil in 2019 and 2020.

Method: this was a follow-up study of breast cancer cases available from the Oncology Panel; a chi-square test and multilevel logistic regression were performed in order to analyze the explanatory variables associated with delay (greater than 60 days) in starting treatment.

Results: 22,956 cases (54.5%) with delay in treatment were identified in 2019 and 17,722 (48.7%) in 2020; the Southeast region (54.6%) had the greatest proportion of delay; delay was greater when treatment was provided outside the municipality of residence and lower in 2020 compared to 2019; most outward flows were to the capital cities in the same Federative Units of residence.

Conclusion: strategies to reduce cancer treatment delay and optimize health care networks in the Federative Units should be prioritized.

MeSH terms

  • Brazil / epidemiology
  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / therapy
  • Female
  • Follow-Up Studies
  • Health Services Accessibility*
  • Humans
  • Residence Characteristics